Silva Pharmaceuticals Limited announcements
119 Dhaka Stock Exchange announcements for Silva Pharmaceuticals Limited (SILVAPHL) since 2018: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (12).
- Category Change
The Company has been placed in 'B' category from existing 'A' category with effect from January 02, 2022 as the Company has approved 5% cash dividend for shareholders excluding the Sponsors/Directors (except ICB) for the year ended on June 30, 2021.
- Resumption after record date
Trading of the shares of the Company will resume on 02.12.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 01.12.2021.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 29.11.2021 to 30.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 01.12.2021.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.29 for July-September 2021 as against Tk. 0.35 for July-September 2020; NOCFPS was Tk. 0.45 for July-September 2021 as against Tk. 0.42 for July-September 2020. NAV per share was Tk. 16.92 as on September 30, 2021 and Tk. 16.63 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 11, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- Dividend Declaration
(Continuation news of SILVAPHL): Date of AGM: 30.12.2021, Time: 11:00 AM, Venue: Digital Platform, Record Date: 01.12.2021. The Company has reported EPS of Tk. 0.88, NAV per share of Tk. 16.63 and NOCFPS of Tk. 1.18 for the year ended on June 30, 2021 as against Tk. 0.87, Tk. 16.10 and Tk. 1.10 respectively for the same period of the previous year. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (28.10.2021) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2021 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.19 for January-March 2021 as against Tk. 0.20 for January-March 2020; EPS was Tk. 0.73 for July 2020-March 2021 as against Tk. 0.75 for July 2019-March 2020. NOCFPS was Tk. 0.96 for July 2020-March 2021 as against Tk. 1.05 for July 2019-March 2020. NAV per share was Tk. 16.48 as on March 31, 2021 and Tk. 16.10 as on June 30, 2020.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2021 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.20 for October-December 2020 as against Tk. 0.26 for October-December 2019; EPS was Tk. 0.54 for July-December 2020 as against Tk. 0.55 for July-December 2019. NOCFPS was Tk. 0.68 for July-December 2020 as against Tk. 0.83 for July-December 2019. NAV per share was Tk. 16.65 as on December 31, 2020 and Tk. 16.10 as on June 30, 2020.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.